Bibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations

腫瘤醫學研究所YANG, CHIH-HSINCHIH-HSINYANGSHIH, JIN-YUANJIN-YUANSHIH2010-06-292018-07-092010-06-292018-07-092009http://ntur.lib.ntu.edu.tw//handle/246246/186849en-USBibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations